Login to Your Account

'LYS' seeks more: Lysogene lines up $43M IPO

By Cormac Sheridan
Staff Writer

Wednesday, January 25, 2017

DUBLIN – Lysogene SA is the first European biotech to dip its toes in the IPO waters in 2017, with plans to raise up to €39.7 million (US$42.7 million) on the Euronext exchange in Paris.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription